Procyon Advisors’s Chemed CHE Stock Holding History

Procyon Advisors’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-38	Closed	-$17K	–	348
2020 Q2	$17K	Sell	38 -11	-22%	-$4.91K	0.01%	563
2020 Q1	$21K	Buy	49 +4	+9%	+$1.79K	0.01%	471
2019 Q4	$20K	Buy	+45	New	+$18.9K	0.01%	491

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Procyon Advisors's CHE Position: Q3 2020 in Review

Procyon Advisors sold out of Chemed (CHE) in Q3 2020, closing a stake of 38 shares — an estimated $17K sold.

Procyon Advisors first reported a position in CHE in Q4 2019 and held it in 3 quarters. The position peaked at $21K in Q1 2020. 446 funds tracked by Wall St. Rank hold CHE as of Q3 2020.

Procyon Advisors reported no remaining Chemed position as of Q3 2020 after selling out during the quarter.
Procyon Advisors sold 38 Chemed shares in Q3 2020, an estimated $17K.
Procyon Advisors first reported a position in Chemed in Q4 2019 and held it in 3 quarters.
Procyon Advisors's Chemed position peaked at $21K in Q1 2020.
446 funds tracked by Wall St. Rank held Chemed as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.